Клоксациллин

Quick links to important sections

Клоксациллин

Treatment option: Abscess

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Клоксациллин

Quick Facts about Cloxacillin

Property Description
Active ingredient Cloxacillin (typically Cloxacillin Sodium)
Form Capsules, oral suspension, powder for injection
Pharmacological class Penicillinase-resistant penicillin, antibacterial agent
Common use Treating susceptible bacterial infections
Origin Semisynthetic

What Type of Antibiotic is Клоксациллин?

Клоксациллин (Cloxacillin) is a potent semisynthetic penicillin that functions as a focused antibacterial agent, chemically derived from the core structure of natural penicillin. It belongs to the specialized class of beta-lactam antibiotics known as penicillinase-resistant penicillins. This distinction is critical because it signifies the drug's resilience against beta-lactamase enzymes produced by some bacteria. This resistance profile is a key differentiating feature from older penicillins. The active component is the substance Cloxacillin, usually administered as its sodium salt.


Composition and Available Pharmaceutical Forms

Cloxacillin is a single-ingredient product, and to accommodate various treatment needs, it is available in several pharmaceutical preparations for both adult and pediatric patients. For milder infections or outpatient care, it is supplied for oral intake as capsules and a liquid suspension. For systemic or severe infections, which require faster and more direct intervention, it is supplied as a sterile powder for injection, which is prepared for intramuscular or intravenous administration in clinical settings. Cloxacillin is classified as a beta-lactam antibacterial, reflecting its role in destroying bacteria by inhibiting their structural formation.


What is the General Purpose of Клоксациллин?

The general purpose of Клоксациллин is to exert a direct bactericidal action—it actively kills susceptible infectious microorganisms to resolve underlying bacterial infections. Its fundamental mechanism involves disrupting the bacteria's ability to synthesize and maintain their cell walls. Its specialized, penicillinase-resistant nature makes it a valuable tool for eliminating infections, particularly those caused by common strains of Staphylococcus that are known to inactivate older, non-resistant penicillins. A common scenario where this class is used is when treating established staphylococcal skin and soft-tissue infections.

What side effects are possible with Клоксациллин?

Cloxacillin: Possible Side Effects and Safety Information

Adverse Reactions

Cloxacillin is generally associated with a risk profile common to penicillin-class antibiotics, with the most frequent adverse reactions involving the gastrointestinal system and hypersensitivity reactions.

  • Common Effects (Gastrointestinal): The most frequently reported effects include nausea, vomiting, diarrhea, abdominal pain, and gas. Prolonged use may lead to superinfection, such as oral or vaginal candidiasis (thrush/yeast infection).
  • Serious and Clinically Significant Reactions: Serious adverse events are rare but require immediate attention. These include potentially fatal anaphylactoid reactions and Severe Cutaneous Adverse Reactions (SCAR) such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
  • Organ-Specific Risks: Other serious, documented risks include Clostridioides difficile-associated diarrhea (CDAD), CNS toxicity (e.g., myoclonus, convulsions/seizures, and depressed consciousness), interstitial nephritis (kidney inflammation), cholestatic hepatitis (liver issues), and hematological disorders (e.g., leukopenia, thrombocytopenia).

Safety Considerations and Restrictions

Area Key Regulatory Statement
Contraindication The drug is contraindicated in patients with a history of hypersensitivity to any penicillin or cephalosporin due to the risk of cross-allergenicity and serious allergic reactions.
Population Risk Renal Impairment and Neonates are noted as at-risk groups. In patients with severe kidney problems or on high doses, there is an increased risk of neurotoxicity due to high serum concentration.
Monitoring For patients on long-term therapy, periodic evaluation of renal, hepatic, and hematopoietic functions is necessary.
Drug-Related Patterns CNS adverse effects, including seizures, are expected when high serum concentrations are attained, particularly in the presence of renal failure or massive doses.

All patients with known penicillin or cephalosporin allergies must avoid this medication. The overall safety structure emphasizes that while mild gastrointestinal upset is common, the critical risks are life-threatening allergic responses and organ system damage, mandating careful patient selection and laboratory monitoring during extended treatment.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation identifies the primary risk of Cloxacillin overdose as Neurotoxicity.

Overdose Scope

Feature Official Regulatory Statements
Documented overdose presentations Signs of toxicity to the Central Nervous System (CNS), including myoclonia and depressed consciousness. Gastrointestinal effects like nausea and diarrhea may also occur.
Physiological systems affected Central Nervous System, Renal System (Nephrotoxicity), and Cardiovascular System (risk of congestive heart failure associated with large sodium doses).
Dose-related or exposure-related factors Risk of neurotoxicity, including convulsions, is increased with very high intravenous doses and may lead to electrolyte imbalance.
Population-specific overdose notes The risk of severe CNS toxicity is heightened in patients with impaired renal function or renal failure. Elderly patients are also documented as being at an increased risk for toxic reactions.
When immediate medical help is required Contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even in the absence of initial symptoms.

Overdose Classifications (High-Level)

Classification Aspect Official Regulatory Statement
Severity classification Symptoms may progress to convulsive seizures, coma, and death if not managed.
Overdose-context constraints No specific antidote is required or known. Treatment is officially defined as symptomatic and supportive.

Resulting Overdose Structure

  • Overdose manifestations center on CNS toxicity, which may progress to convulsive seizures and potentially fatal outcomes, especially in those with renal impairment.
  • The required action is to immediately contact emergency services or a poison control center, followed by cessation or reduction of the drug dosage.
  • Management is strictly symptomatic and supportive, and official documents specify that renal and haematological systems should be monitored in high-dose situations.

Connection to the overall overdose profile Regulatory documents define the Cloxacillin overdose profile by its potential for severe neurotoxicity and the mandatory requirement for immediate emergency medical contact. The official guidance specifies that management is supportive care, necessitating monitoring of physiological systems given the lack of a specified antidote.

Therapeutic Uses of Клоксациллин

What Клоксациллин treats: Main Uses and Benefits

Cloxacillin, classified as a penicillinase-resistant penicillin, is commonly used to treat infections caused by susceptible organisms, primarily beta-lactamase-producing staphylococci. This medication is applied across therapeutic domains involving acute or disruptive symptom patterns.

The therapeutic scope includes serious, systemic conditions presenting with systemic or localized discomfort, such as septicemia and infections in vital organs, as well as localized acute infections including cellulitis, impetigo, and osteomyelitis. When applied in clinical settings that involve acute or unstable symptom patterns, Cloxacillin supports efforts to manage the progression of the disease and is applied in addressing visible and painful symptoms related to inflammatory or irritative states.


Quick Fact: Relief for Localized Discomfort

The medication plays a role in managing the overall symptom burden, contributing to easing the acute pain, redness, and swelling associated with active bacterial infections. When symptoms become intense or disruptive, Cloxacillin may assist with managing systemic signs like fever and severe malaise.

Regulatory References

  1. Health Canada Product Monograph

Eligibility and Restrictions for Use

Cloxacillin Eligibility and Restrictions

Eligibility for Cloxacillin is strictly determined by official regulatory guidelines, focusing on patient history, age, and physiological status.

Who Must Not Use Cloxacillin (Contraindications)

Classification Population/Condition
Absolute Prohibition Known hypersensitivity or history of allergic reactions to penicillin or any other beta-lactam antibiotic.
Absolute Prohibition Known hypersensitivity to cephalosporins (due to risk of cross-sensitivity).

Populations Requiring Special Consideration

Domain Restriction/Cautionary Status
Age-Related Use Safety and effectiveness are not established or experience is limited in children under one year of age (infants).
Organ Function Patients with severe renal impairment may require dosage adjustment due to increased risk of central nervous system (CNS) adverse effects.
Pregnancy/Lactation Use during pregnancy is permitted only when clearly established as necessary (Pregnancy Category B). Trace amounts pass into breast milk, requiring caution for the nursing infant.

Cloxacillin must only be administered when no contraindications are present and within the established use guidelines for the patient's age and clinical status.

What should I know about interactions with other medicines?

The regulatory documentation for Cloxacillin interactions defines several mandatory restrictions and pharmacokinetic outcomes with other products.

Exposure Modification

Co-administration with Probenecid is documented to enhance the serum concentration of Cloxacillin by competing for renal tubular secretion. Cloxacillin may increase the serum concentration and toxicity of Methotrexate, which is a significant clinical constraint. Conversely, Cloxacillin may decrease the serum concentrations of the active metabolites of Mycophenolate.

Pharmacodynamic Effects and Restrictions

Cloxacillin may diminish or enhance the anticoagulant effect of Vitamin K Antagonists (e.g., Warfarin). A restriction is noted with live attenuated vaccines, such as the Typhoid Vaccine, as the antibacterial may diminish the therapeutic effect, requiring vaccination postponement. The drug is listed as incompatible for co-administration in solution with agents including Aminoglycosides, Tetracyclines, Erythromycin, and Polymyxin B. Co-administration with BCG (Intravesical) is advised to be avoided.

Administration Timing Requirements

Oral Cloxacillin absorption is reduced and delayed by food. Regulatory requirements specify that the drug must be administered 1 to 2 hours before or 2 hours after meals to ensure adequate absorption.

Mechanism of Action

Covalent Inhibition of Bacterial Cell Wall Synthesis

Cloxacillin initiates its action by targeting Penicillin-Binding Proteins (PBPs), a group of essential bacterial enzymes. The drug forms an irreversible covalent bond with these PBPs, permanently deactivating them. This inhibition prevents the crucial cross-linking of peptidoglycan strands, thereby blocking the final construction step of the rigid bacterial cell wall. This molecular failure compromises the pathogen's structure.


Exploitation of Osmotic Instability

The failure to synthesize a functional cell wall critically compromises the bacterium’s ability to withstand its own high internal osmotic pressure. The result of this structural defect is a rapid swelling and rupture (lysis), which constitutes the bactericidal effect. This mechanism leads directly to the destruction of susceptible bacterial populations.


Inherent Resistance to beta-Lactamases

Cloxacillin's chemical structure includes a bulky side chain that physically shields the beta-lactam ring. This steric hindrance obstructs the access of bacterial beta-lactamase enzymes to the drug molecule. This structural feature allows the PBP-inhibiting action to proceed against strains that express beta-lactamase enzymes.

Dosage and Administration Information

Cloxacillin administration is determined by the required route and the available pharmaceutical form. The medicine is authorized for both oral intake and parenteral administration via the intravenous (IV) or intramuscular (IM) routes, corresponding to available capsules, oral suspension, and sterile powder for injection, respectively.

The standardized adult dosing regimen requires the medicine to be taken in a divided use pattern of four times daily, maintaining an interval of every six hours to ensure consistent drug levels. Dosing for general infections typically ranges from 250 mg to 500 mg per dose, with the total daily limit not exceeding 6 grams for severe cases.

A key requirement for oral administration is timing: Cloxacillin must be taken on an empty stomach, generally one to two hours before or two hours after consuming food, as absorption is significantly reduced by meals. For pediatric patients, dosing is calculated based on weight (e.g., 50 mg/kg/day) and then administered in four equal, divided doses.

Both the oral granules and the sterile powder must undergo reconstitution with the specified volume of water or sterile diluent immediately before use. The duration of use is defined by the full course prescribed, typically extending 48 to 72 hours after clinical signs have resolved.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Клоксациллин

Evidence Structure for Infections Caused by Susceptible Staphylococci

Research has was studied for Cloxacillin primarily in the context of conditions associated with acute or disruptive episodes caused by Staphylococcus bacteria that are susceptible to penicillin-based drugs. The evidence landscape includes retrospective studies, which look back at patient data, and planned clinical trials explore research patterns related to these microorganisms. Studies focused on outcomes monitoring physiological strain or stress, such as whether the resolution of the infection was observed, if systemic signs like fever and general unwellness resolved, and whether the infection returned (relapse) over a period of time. Findings from this research data show patterns related to how these outcomes evolved in the observed populations during the study period.


Evidence Structure for Serious Systemic and Localized Infections

Research Structure for Septicemia and Bone Infections (Osteomyelitis)

For serious systemic infections like septicemia (blood infection), research was evaluated in retrospective cohort studies. Similar research was studied for deep-seated bone infections, such as osteomyelitis. In these cases, research examined outcomes related to recurrence, with some studies tracking observations up to six months. Findings describe patterns observed in the studies related to survival rates and how the infection evolved, but some comparative research in this area sample sizes were modest and research is ongoing.

Research Structure for Skin and Soft Tissue Infections (Cellulitis, Impetigo)

The evidence for skin infections like cellulitis and impetigo primarily stems from systematic reviews. These reviews was studied for the drug's use in outcomes linked to inflammatory or irritative states such as acute pain, redness, and swelling. While the findings contribute to the broader evidence landscape, specific research trials focused only on Cloxacillin for impetigo is limited.


Evidence in Specific Populations

Research was evaluated in both adults and pediatric patients (children). The structure of research shows that studies was evaluated for its use across various age groups, including contexts involving common infections. However, data for certain groups remain insufficient. Research focusing on specific comorbidity groups or very elderly populations is limited, meaning results apply only to the populations studied, and subgroup findings are uncertain in broader groups.


What is Still Uncertain About Cloxacillin's Research Base

The current body of research contains several limitations. Some comparative evidence relies on studies where sample sizes were modest, which may impact the certainty of the findings. The overall evidence quality varies across studies, and the reliance on retrospective studies introduces a risk of bias that can affect the observed patterns. Overall, long-term effects are not fully established, and comparative evidence is lacking for many direct comparisons, meaning research is ongoing.

Key Studies & References

  1. Cloxacillin Health Canada Product Monograph (Clinical Use and Indications)

Frequently Asked Questions (FAQ)

Common questions about Клоксациллин (FAQ)


Q: How quickly should I expect to feel better after starting Cloxacillin?

According to official information regarding antibacterial treatments, the prescribed full course of treatment is important to follow. Clinical signs of the infection are expected to begin resolving within the first 48 to 72 hours after treatment has begun. If symptom improvement is not observed within the first few days, seeking advice from a healthcare provider is generally indicated.


Q: Does food affect how Cloxacillin is absorbed?

Yes, regulatory guidance states that the absorption of oral Cloxacillin is reduced and delayed by food. Taking the medicine with a meal may prevent adequate amounts of the drug from entering the body. This is why official product information specifies administration on an empty stomach, as this condition supports adequate absorption.


Q: Can older adults safely use Cloxacillin?

Official product information does not list age alone as a contraindication for older adults. However, cautionary statements exist regarding use in patients with severe renal impairment (significant kidney problems), as regulatory information indicates an increased risk of neurological side effects. Monitoring of physiological function is noted as being necessary in some patient profiles.


Q: Does Cloxacillin cause drowsiness or affect my ability to drive?

Official documentation for some formulations states that Cloxacillin does not typically affect a patient's ability to drive or operate machinery. However, the drug is known to cause Central Nervous System (CNS) adverse effects like seizures or depressed consciousness, especially when high drug concentrations build up. If severe CNS side effects are experienced, regulatory information advises against activities that require full mental alertness, such as driving.


Q: What if I start taking Cloxacillin and my symptoms worsen initially?

If symptoms do not improve, or if they appear to worsen after starting Cloxacillin, official guidance suggests that informing the healthcare provider promptly is generally indicated in such situations. Clinical resolution of the infection is expected to be observed within the full treatment period.


Q: Does taking Cloxacillin cause stomach upset or diarrhea?

Yes, common adverse effects documented in official labeling frequently involve the gastrointestinal system. These include symptoms like nausea, vomiting, abdominal pain, gas, and diarrhea.


Q: What should I do if I experience mild side effects?

General patient information suggests that if common, mild side effects like an upset stomach or nausea persist or worsen, consulting with a prescribing healthcare provider or pharmacist is generally indicated. This allows them to review the effects relative to expected outcomes.


Q: Is Cloxacillin a broad-spectrum or narrow-spectrum antibiotic?

Cloxacillin is classified by official bodies as a narrow-spectrum beta-lactam antibiotic. This means it is highly focused in its activity, primarily designed to target specific bacteria, such as strains of Staphylococcus that are resistant to natural penicillin.


Q: What are the signs of liver problems with Cloxacillin?

Serious liver-related risks, such as cholestatic hepatitis, are documented in official safety information. General patient resources that accompany drug labeling may describe signs of severe liver issues, including dark urine and yellowing of the eyes or skin (jaundice).


Q: Can I take Cloxacillin if I have a history of inflammatory bowel disease?

Official documentation notes that Cloxacillin can carry a risk of Clostridioides difficile-associated diarrhea (CDAD), which can be severe. Patients with a history of serious gastrointestinal issues, including colitis or inflammatory bowel conditions, are often stated as requiring careful monitoring during treatment.


Q: Are there specific laboratory tests required when using Cloxacillin?

Yes, official documentation advises that for patients receiving long-term therapy, periodic evaluations are necessary. These typically include monitoring of renal (kidney), hepatic (liver), and hematopoietic (blood cell formation) functions.


Q: Can Cloxacillin be prescribed by a dentist?

Regulations often allow licensed dentists to prescribe antibiotics for conditions that fall within the scope of dental practice, such as acute dental infections. Cloxacillin may be considered when a susceptible staphylococcal infection is suspected or confirmed as the cause of the dental issue.


Q: Are there different brands or generic names for the drug Cloxacillin?

Yes, Cloxacillin is the generic name of the active ingredient, most commonly used as Cloxacillin Sodium. The drug has been marketed under various brand names depending on the country and the manufacturer.


Q: Does Cloxacillin affect the immune system?

Official labeling documents adverse reactions that involve the hematopoietic system, which is related to blood cell formation and immune function. These effects include rare conditions such as agranulocytosis and leukopenia, which relate to white blood cell count.


Q: What are the regulatory classifications of the drug (e.g., prescription-only)?

In most jurisdictions, Cloxacillin is classified by national drug agencies as a prescription-only medicine or equivalent. This means it requires authorization from a licensed healthcare provider before it can be legally dispensed.


Q: Does the age of the patient change the expected effects of Cloxacillin?

The expected effects can change with age, particularly in very young patients. Official product information notes that neonates (newborns) are at risk for increased drug concentrations due to immature kidney function. This can lead to a higher potential for dose-related side effects, such as CNS adverse effects.


Q: Can Cloxacillin be used for dental infections?

Cloxacillin is indicated for use against susceptible Staphylococcus infections. While official guidelines recommend specific antibiotics for many dental infections, Cloxacillin may be utilized when a staphylococcal component to the infection is suspected or confirmed.


Q: Are there any lifestyle restrictions mentioned in the official guides for Cloxacillin?

Official guides state the drug must be taken on an empty stomach to ensure proper absorption. They also advise caution for activities like driving if the patient experiences neurological or CNS side effects. Generally, there are no universal restrictions regarding sun exposure mentioned.


Q: How is the effectiveness of Cloxacillin measured in research?

Clinical effectiveness in patients is measured in research through specified outcomes, such as the resolution of clinical signs of infection and monitoring for recurrence rates. Potency in the medicine itself is measured using regulatory standards like microbiological assays.


Q: What are the signs of a serious allergic reaction to Cloxacillin?

Signs of a serious allergic reaction, as documented in official safety labeling, include: fever that does not go away, a new or worsening rash or hives, swelling (especially of the face, tongue, or throat), severe dizziness, and trouble breathing.

How should Клоксациллин be stored and disposed of?

Official Storage and Disposal Requirements for Cloxacillin

Regulatory documents define specific conditions for storing and disposing of Cloxacillin to ensure product stability and safety. These requirements govern temperature, environmental protection, and final disposal.

Storage/Disposal Domain Regulatory Requirement
Temperature & Environment Store below 30 C. Protect from light and moisture (keep in a dry place).
Handling & Stability Keep the container tightly closed. Protect from strong oxidizing agents. Stability is limited after reconstitution, requiring adherence to the specified discard date.
Child Safety Keep the medication out of the reach and sight of children.
Disposal Protocol Dispose of unused or expired Cloxacillin according to local regulatory programs, such as drug take-back options. Do not flush down a toilet or release into waterways, preventing environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Клоксациллин found in:

A-Z Index: